Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NY:BTX)
6.460
+0.020
(+0.31%)
Streaming Delayed Price
Updated: 3:27 PM EST, Feb 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 607,695 |
| Open | 6.460 |
| Bid (Size) | 6.450 (5,300) |
| Ask (Size) | 6.460 (5,000) |
| Prev. Close | 6.440 |
| Today's Range | 6.400 - 6.520 |
| 52wk Range | 5.100 - 8.120 |
| Shares Outstanding | 7,848,889 |
| Dividend Yield | 4.92% |
Top News
More News
Performance
More News
Read More
Frequently Asked Questions
Is Brooklyn ImmunoTherapeutics, Inc. - Common Stock publicly traded?
Yes, Brooklyn ImmunoTherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Brooklyn ImmunoTherapeutics, Inc. - Common Stock trade on?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock is BTX on the New York Stock Exchange
What is the current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 6.460
When was Brooklyn ImmunoTherapeutics, Inc. - Common Stock last traded?
The last trade of Brooklyn ImmunoTherapeutics, Inc. - Common Stock was at 02/13/26 03:27 PM ET
What is the market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 50.70M
How many shares of Brooklyn ImmunoTherapeutics, Inc. - Common Stock are outstanding?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock has 51M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
